Acrivon Therapeutics, Inc. · NASDAQ:ACRV
Peterson Katharine sold 107 Acrivon Therapeutics, Inc. shares (Form 4)
Traded Nov 17, 2026 · Filed Nov 19, 2026
On Nov 17, 2026, Peterson Katharine (Chief Accounting Officer) sold 107 Acrivon Therapeutics, Inc. shares at US$1.45 for US$155, leaving 17,926 shares. Filed Nov 19, 2026 (Form 4).
- Sold
- 107 shares
- Price
- US$1.45
- Value
- US$155
- Holding after
- 17,926 shares
- Trading plan
- No
- Role
- Chief Accounting Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Nov 17, 2026 | Common Stock | Sale | 107 | US$1.45 | 17,926 | Direct |
Source
Download original · View original at SEC
Related
- Acrivon Therapeutics, Inc.
- Peterson Katharine
- Acrivon Therapeutics, Inc. shareholders
- Form 4 · Peterson Katharine · Aug 20, 2026
- Form 4 · Peterson Katharine · May 20, 2026
- Form 4 · Peterson Katharine · May 18, 2026
- Form 4 · Devroe Eric · Nov 19, 2026
- Form 4 · Blume-Jensen Peter · Nov 19, 2026
- Form 4 · Miller Mary · Nov 19, 2026
- Form 4 · Gamelin Erick · Nov 19, 2026
- Form 4 · Miller Mary · Oct 26, 2026